Atlas Trials

Healthy Subjects and Atopic Dermatitis Subjects

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Healthy Subjects and Atopic Dermatitis Subjects

RecordFirmDate
A Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic Dermatitis (NCT01614756)Bristol-Myers Squibb2012-07-01

Track Healthy Subjects and Atopic Dermatitis Subjects automatically

Every clearance here is in the API, with alerts when new ones post.